Home DailyMed c219eed5-e59a-4197-8b85-4aabba89fefb National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:36:48 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022117-001 SAPHRIS ASENAPINE MALEATE EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 N022117-002 SAPHRIS ASENAPINE MALEATE EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 N022117-003 SAPHRIS ASENAPINE MALEATE EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 21 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022117-001 7741358 2026-04-06 U-1064 Drug substance, Drug product 2017-02-10 N022117-001 7741358 2026-04-06 U-1960 Drug substance, Drug product 2017-02-10 N022117-001 7741358 2026-04-06 U-1961 Drug substance, Drug product 2017-02-10 N022117-001 7741358 2026-04-06 U-1962 Drug substance, Drug product 2017-02-10 N022117-001 7741358 2026-04-06 U-1963 Drug substance, Drug product 2017-02-10 N022117-001 8022228 2026-04-06 Drug substance, Drug product 2014-07-29 N022117-001 7741358*PED 2026-10-06 Pediatric extension N022117-001 8022228*PED 2026-10-06 Pediatric extension N022117-002 7741358 2026-04-06 U-1064 Drug substance, Drug product 2017-02-10 N022117-002 7741358 2026-04-06 U-1960 Drug substance, Drug product 2017-02-10 N022117-002 7741358 2026-04-06 U-1961 Drug substance, Drug product 2017-02-10 N022117-002 7741358 2026-04-06 U-1962 Drug substance, Drug product 2017-02-10 N022117-002 7741358 2026-04-06 U-1963 Drug substance, Drug product 2017-02-10 N022117-002 8022228 2026-04-06 Drug substance, Drug product 2014-07-29 N022117-002 7741358*PED 2026-10-06 Pediatric extension N022117-002 8022228*PED 2026-10-06 Pediatric extension N022117-003 7741358 2026-04-06 U-1893 Drug substance, Drug product 2016-09-12 N022117-003 7741358 2026-04-06 U-1966 Drug substance, Drug product 2016-09-12 N022117-003 8022228 2026-04-06 Drug substance, Drug product 2016-09-12 N022117-003 7741358*PED 2026-10-06 Pediatric extension N022117-003 8022228*PED 2026-10-06 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022117-002 SAPHRIS EQ 10MG BASE TABLET / SUBLINGUAL AB RLD, RS 2009-08-13 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022117-003 SAPHRIS EQ 2.5MG BASE TABLET / SUBLINGUAL AB RLD 2015-03-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022117-001 SAPHRIS EQ 5MG BASE TABLET / SUBLINGUAL AB RLD 2009-08-13 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 111 observed states.
Observed Orange Book patent history# Patent history page 1 of 25 · 993 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N022117-001 7741358 2026-04-06 U-1960 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 7741358 2026-04-06 U-1064 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 7741358 2026-04-06 U-1961 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 7741358 2026-04-06 U-1962 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 7741358 2026-04-06 U-1963 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 8022228 2026-04-06 Drug substance, Drug product 2014-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 7741358*PED 2026-10-06 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-001 8022228*PED 2026-10-06 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 7741358 2026-04-06 U-1963 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 7741358 2026-04-06 U-1064 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 7741358 2026-04-06 U-1961 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 7741358 2026-04-06 U-1960 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 7741358 2026-04-06 U-1962 Drug substance, Drug product 2017-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 8022228 2026-04-06 Drug substance, Drug product 2014-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 7741358*PED 2026-10-06 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-002 8022228*PED 2026-10-06 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-003 7741358 2026-04-06 U-1966 Drug substance, Drug product 2016-09-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-003 7741358 2026-04-06 U-1893 Drug substance, Drug product 2016-09-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-003 8022228 2026-04-06 Drug substance, Drug product 2016-09-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-003 7741358*PED 2026-10-06 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022117-003 8022228*PED 2026-10-06 Pediatric extension 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022117-001 7741358 2026-04-06 U-1960 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 7741358 2026-04-06 U-1064 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 7741358 2026-04-06 U-1961 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 7741358 2026-04-06 U-1962 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 7741358 2026-04-06 U-1963 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 8022228 2026-04-06 Drug substance, Drug product 2014-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 7741358*PED 2026-10-06 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-001 8022228*PED 2026-10-06 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 7741358 2026-04-06 U-1963 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 7741358 2026-04-06 U-1064 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 7741358 2026-04-06 U-1961 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 7741358 2026-04-06 U-1960 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 7741358 2026-04-06 U-1962 Drug substance, Drug product 2017-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 8022228 2026-04-06 Drug substance, Drug product 2014-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 7741358*PED 2026-10-06 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-002 8022228*PED 2026-10-06 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-003 7741358 2026-04-06 U-1966 Drug substance, Drug product 2016-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-003 7741358 2026-04-06 U-1893 Drug substance, Drug product 2016-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022117-003 8022228 2026-04-06 Drug substance, Drug product 2016-09-12 caaa826d4ba7…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.